Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Rang in Aktien #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Aktienkurs
$4.00
Zuletzt synchronisiert: 2026-08-20
Marktkapitalisierung
$75.37M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
12.99%
Land
US
Handel RetinalGenix Technologies Inc. (RTGN)

Kategorie

Kursverlauf für RetinalGenix Technologies Inc. (RTGN)
Höchster Schlusskurs: $4.00 am 2026-08-01

Niedrigster Schlusskurs: $6.94 am 2014-03-01
Kursverlauf der Aktie von RetinalGenix Technologies Inc. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 9.70%
2025 100.00%
2024 -48.22%
2023 -65.67%
2022 116.03%
2015 10.30%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$116.64 -12.03%
US
$330.03 -16.28%
US
$93.47 0.81%
IE
$50.38 -52.55%
US
$47.68 -15.22%
DE